Airway management during transoral robotic surgery for head and neck cancers: a French GETTEC group survey.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 11 06 2021
accepted: 15 11 2021
pubmed: 24 1 2022
medline: 27 5 2022
entrez: 23 1 2022
Statut: ppublish

Résumé

The aim of the survey was to define the indications for preventive tracheostomy in transoral robotic surgery (TORS) for head and neck cancers. From October 2019 to January 2020, an online questionnaire was e-mailed to French surgical ENT teams with considerable experience of the TORS procedure (Gettec group). A descriptive analysis of the answers was performed. Eighteen French surgical teams answered the questionnaire. For 77.8% of the surgical teams, a past history of radiotherapy with residual edema was an indication for prophylactic tracheostomy, and for 88.9%, > 75 mg of antiplatelet medication or anticoagulation treatment was an indication. Early preventive tracheostomy during TORS can protect airway from uncommon but potentially life-threatening complications, such as transoral hemorrhage or airway edema. We recommend it in high-risk situations, such as a past history of radiotherapy or antiplatelet therapy associated with large resections. Further studies are needed to establish evidence-based recommendations.

Identifiants

pubmed: 35066651
doi: 10.1007/s00405-021-07188-4
pii: 10.1007/s00405-021-07188-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3619-3627

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Weinstein GS, O’Malley BW, Snyder W, Hockstein NG (2007) Transoral robotic surgery: supraglottic partial laryngectomy. Ann Otol Rhinol Laryngol 116:19–23. https://doi.org/10.1177/000348940711600104
doi: 10.1177/000348940711600104 pubmed: 17305273
Weinstein GS, O’Malley BW, Snyder W, Sherman E, Quon H (2007) Transoral robotic surgery: radical tonsillectomy. Arch Otolaryngol Head Neck Surg 133:1220. https://doi.org/10.1001/archotol.133.12.1220
doi: 10.1001/archotol.133.12.1220 pubmed: 18086963
de Campora E, Radici M, de Campora L (2001) External versus endoscopic approach in the surgical treatment of glottic cancer. Eur Arch Otorhinolaryngol 258:533–536. https://doi.org/10.1007/s004050100402
doi: 10.1007/s004050100402 pubmed: 11829191
Van Abel KM, Quick MH, Graner DE, Lohse CM, Price DL, Price KAR et al (2019) Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond. Am J Otolaryngol 40:729–734. https://doi.org/10.1016/j.amjoto.2019.07.003
doi: 10.1016/j.amjoto.2019.07.003 pubmed: 31303455
Razafindranaly V, Lallemant B, Aubry K, Moriniere S, Vergez S, Mones ED et al (2016) Clinical outcomes with transoral robotic surgery for supraglottic squamous cell carcinoma: experience of a French evaluation cooperative subgroup of GETTEC: clinical outcomes with transoral robotic surgery for supraglottic SCC. Head Neck 38:E1097–E1101. https://doi.org/10.1002/hed.24163
doi: 10.1002/hed.24163 pubmed: 26435046
Olsen SM, Moore EJ, Koch CA, Price DL, Kasperbauer JL, Olsen KD (2012) Transoral robotic surgery for supraglottic squamous cell carcinoma. Am J Otolaryngol 33:379–384. https://doi.org/10.1016/j.amjoto.2011.10.007
doi: 10.1016/j.amjoto.2011.10.007 pubmed: 22133967
Hassid S, Van der Vorst S, Delahaut G, Ambroise J, Lawson G (2020) Transoral robotic surgery hypopharyngectomy (TORSH): feasibility and outcomes. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-05984-y
doi: 10.1007/s00405-020-05984-y pubmed: 32367147
Vergez S, Lallemant B, Ceruse P, Moriniere S, Aubry K, De Mones E et al (2012) Initial multi-institutional experience with transoral robotic surgery. Otolaryngol Head Neck Surg 147:475–481. https://doi.org/10.1177/0194599812443221
doi: 10.1177/0194599812443221 pubmed: 22473832
Aubry K, Vergez S, de Mones E, Moriniere S, Choussy O, Malard O et al (2016) Morbidity and mortality revue of the French group of transoral robotic surgery: a multicentric study. J Robot Surg 10:63–67. https://doi.org/10.1007/s11701-015-0542-z
doi: 10.1007/s11701-015-0542-z pubmed: 26559537
Hockstein NG, O’Malley BW, Weinstein GS (2006) Assessment of intraoperative safety in transoral robotic surgery. Laryngoscope 116:165–168. https://doi.org/10.1097/01.mlg.0000199899.00479.75
doi: 10.1097/01.mlg.0000199899.00479.75 pubmed: 16467698
Lallemant B, Moriniere S, Ceruse P, Lebalch M, Aubry K, Hans S et al (2017) Transoral robotic surgery for squamous cell carcinomas of the posterior pharyngeal wall. Eur Arch Otorhinolaryngol 274:4211–4216. https://doi.org/10.1007/s00405-017-4771-9
doi: 10.1007/s00405-017-4771-9 pubmed: 29032418
Mazerolle P, Philouze P, Garrel R, Aubry K, Morinière S, El Bedoui S et al (2018) Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: a French GETTEC group study. Oral Oncol 86:165–170. https://doi.org/10.1016/j.oraloncology.2018.09.014
doi: 10.1016/j.oraloncology.2018.09.014 pubmed: 30409296
Hay A, Migliacci J, Karassawa Zanoni D, Boyle JO, Singh B, Wong RJ et al (2018) Haemorrhage following transoral robotic surgery. Clin Otolaryngol 43:638–644. https://doi.org/10.1111/coa.13041
doi: 10.1111/coa.13041 pubmed: 29194991
Asher SA, White HN, Kejner AE, Rosenthal EL, Carroll WR, Magnuson JS (2013) Hemorrhage after transoral robotic-assisted surgery. Otolaryngol Head Neck Surg 149:112–117. https://doi.org/10.1177/0194599813486254
doi: 10.1177/0194599813486254 pubmed: 23585156
Chia SH, Gross ND, Richmon JD (2013) Surgeon experience and complications with transoral robotic surgery (TORS). Otolaryngol Head Neck Surg 149:885–892. https://doi.org/10.1177/0194599813503446
doi: 10.1177/0194599813503446 pubmed: 24013139
Parhar HS, Gausden E, Patel J, Prisman E, Anderson DW, Durham JS et al (2018) Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma. Head Neck 40:2416–2423. https://doi.org/10.1002/hed.25362
doi: 10.1002/hed.25362 pubmed: 30102813
Stokes W, Ramadan J, Lawson G, Ferris FRL, Holsinger FC, Turner MT (2020) Bleeding complications after transoral robotic surgery: a meta-analysis and systematic review. Laryngoscope. https://doi.org/10.1002/lary.28580
doi: 10.1002/lary.28580 pubmed: 32108347
Turner MT, Stokes WA, Stokes CM, Hassid S, Holsinger FC, Lawson G (2021) Airway and bleeding complications of transoral robotic supraglottic laryngectomy (TORS-SGL): A systematic review and meta-analysis. Oral Oncol 118:105301. https://doi.org/10.1016/j.oraloncology.2021.105301
doi: 10.1016/j.oraloncology.2021.105301 pubmed: 33940531
Gleysteen J, Troob S, Light T, Brickman D, Clayburgh D, Andersen P et al (2017) The impact of prophylactic external carotid artery ligation on postoperative bleeding after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. Oral Oncol 70:1–6. https://doi.org/10.1016/j.oraloncology.2017.04.014
doi: 10.1016/j.oraloncology.2017.04.014 pubmed: 28622885
Zeitouni AG, Kost KM (1994) Tracheostomy: a retrospective review of 281 cases. J Otolaryngol 23:61–66
pubmed: 8170024
Goldenberg D, Ari EG, Golz A, Danino J, Netzer A, Joachims HZ (2000) Tracheotomy complications: a retrospective study of 1130 cases. Otolaryngol Head Neck Surg 123:495–500. https://doi.org/10.1067/mhn.2000.105714
doi: 10.1067/mhn.2000.105714 pubmed: 11020193
Meier J, Wunschel M, Angermann A, Ettl T, Metterlein T, Klingelhöffer C et al (2019) Influence of early elective tracheostomy on the incidence of postoperative complications in patients undergoing head and neck surgery. BMC Anesthesiol 19:43. https://doi.org/10.1186/s12871-019-0715-9
doi: 10.1186/s12871-019-0715-9 pubmed: 30922231 pmcid: 6439993
Waldron J, Padgham ND, Hurley SE (1990) Complications of emergency and elective tracheostomy: a retrospective study of 150 consecutive cases. Ann R Coll Surg Engl 72:218–220
pubmed: 2382943 pmcid: 2499257
Mendelsohn AH, Remacle M, Van Der Vorst S, Bachy V, Lawson G (2013) Outcomes following transoral robotic surgery: supraglottic laryngectomy: TORS supraglottic laryngectomy. Laryngoscope 123:208–214. https://doi.org/10.1002/lary.23621
doi: 10.1002/lary.23621 pubmed: 23008093
Kayhan FT, Kaya KH, Altintas A, Sayin I (2014) Transoral robotic supraglottic partial laryngectomy. J Craniofac Surg 25:1422–1426. https://doi.org/10.1097/SCS.0000000000000572
doi: 10.1097/SCS.0000000000000572 pubmed: 24911606
Mandal R, Duvvuri U, Ferris RL, Kaffenberger TM, Choby GW, Kim S (2016) Analysis of post-transoral robotic-assisted surgery hemorrhage: frequency, outcomes, and prevention: post-transoral robotic-assisted surgery hemorrhage. Head Neck 38:E776–E782. https://doi.org/10.1002/hed.24101
doi: 10.1002/hed.24101 pubmed: 25916790
Pollei TR, Hinni ML, Moore EJ, Hayden RE, Olsen KD, Casler JD et al (2013) Analysis of postoperative bleeding and risk factors in transoral surgery of the oropharynx. JAMA Otolaryngol Head Neck Surg 139:1212. https://doi.org/10.1001/jamaoto.2013.5097
doi: 10.1001/jamaoto.2013.5097 pubmed: 24113922
Park YM, Kim WS, De Virgilio A, Lee SY, Seol JH, Kim S-H (2012) Transoral robotic surgery for hypopharyngeal squamous cell carcinoma: 3-Year oncologic and functional analysis. Oral Oncol 48:560–566. https://doi.org/10.1016/j.oraloncology.2011.12.011
doi: 10.1016/j.oraloncology.2011.12.011 pubmed: 22265334
Park YM, Lee WJ, Lee JG, Lee WS, Choi EC, Chung SM et al (2009) Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech 19:361–368. https://doi.org/10.1089/lap.2008.0320
doi: 10.1089/lap.2008.0320
Park YM, Kim WS, Byeon HK, De Virgilio A, Jung JS, Kim S-H (2010) Feasiblity of transoral robotic hypopharyngectomy for early-stage hypopharyngeal carcinoma. Oral Oncol 46:597–602. https://doi.org/10.1016/j.oraloncology.2010.05.003
doi: 10.1016/j.oraloncology.2010.05.003 pubmed: 20619721
Stubbs VC, Rajasekaran K, Gigliotti AR, Mahmoud AF, Brody RM, Newman JG et al (2018) Management of the airway for transoral robotic supraglottic partial laryngectomy. Front Oncol 8:312. https://doi.org/10.3389/fonc.2018.00312
doi: 10.3389/fonc.2018.00312 pubmed: 30155444 pmcid: 6102950
Jeyarajah J, Ahmad I, Jacovou E (2018) Anaesthesia and perioperative care for transoral robotic surgery. ORL J Otorhinolaryngol Relat Spec 80:125–133. https://doi.org/10.1159/000490598
doi: 10.1159/000490598 pubmed: 30278463
Kucur C, Durmus K, Gun R, Old MO, Agrawal A, Teknos TN et al (2016) Safety and efficacy of concurrent neck dissection and transoral robotic surgery: safety and efficacy of concurrent neck dissection and transoral robotic surgery. Head Neck 38:E519–E523. https://doi.org/10.1002/hed.24033
doi: 10.1002/hed.24033 pubmed: 25783843
Meulemans J, Bijnens J, Delaere P, Vander PV (2018) Up-front and salvage transoral laser microsurgery for early glottic squamous cell carcinoma: a single centre retrospective case series. Front Oncol 8:186. https://doi.org/10.3389/fonc.2018.00186
doi: 10.3389/fonc.2018.00186 pubmed: 29892574 pmcid: 5985398
Park YM, Byeon HK, Chung HP, Choi EC, Kim S-H (2013) Comparison of treatment outcomes after transoral robotic surgery and supraglottic partial laryngectomy: our experience with seventeen and seventeen patients respectively. Clin Otolaryngol 38:270–274. https://doi.org/10.1111/coa.12101
doi: 10.1111/coa.12101 pubmed: 23441587
Motz K, Chang H-Y, Quon H, Richmon J, Eisele DW, Gourin CG (2017) Association of transoral robotic surgery with short-term and long-term outcomes and costs of care in oropharyngeal cancer surgery. JAMA Otolaryngol Head Neck Surg 143:580. https://doi.org/10.1001/jamaoto.2016.4634
doi: 10.1001/jamaoto.2016.4634 pubmed: 28358930 pmcid: 5824232
Kelly K, Johnson-Obaseki S, Lumingu J, Corsten M (2014) Oncologic, functional and surgical outcomes of primary transoral robotic surgery for early squamous cell cancer of the oropharynx: a systematic review. Oral Oncol 50:696–703. https://doi.org/10.1016/j.oraloncology.2014.04.005
doi: 10.1016/j.oraloncology.2014.04.005 pubmed: 24917389

Auteurs

Valentine Poissonnet (V)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Hôpital Larrey, Toulouse, France.

Emilien Chabrillac (E)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Hôpital Larrey, Toulouse, France.

Philippe Schultz (P)

Otolaryngology, Head and Neck Surgery Department, Hautepierre Hospital, Strasbourg, France.

Sylvain Morinière (S)

Otolaryngology, Head and Neck Surgery Department, University Hospital Bretonneau, Tours, France.

Philippe Gorphe (P)

Otolaryngology, Head and Neck Surgery Department, Gustave Roussy Institute, Villejuif, France.

Bertrand Baujat (B)

Otolaryngology, Head and Neck Surgery Department, Tenon Hospital, Paris, France.

Renaud Garrel (R)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Montpellier, Montpellier, France.

Audrey Lasne-Cardon (A)

Otolaryngology, Head and Neck Surgery Department, François Baclesse Centre, Caen, France.

Alexandre Villeneuve (A)

Otolaryngology, Head and Neck Surgery Department, Georges-Pompidou European Hospital, Paris, France.

Guillaume Chambon (G)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Nîmes, Nîmes, France.

Nicolas Fakhry (N)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Marseille, Marseille, France.

Karine Aubry (K)

Otolaryngology, Head and Neck Surgery Department, University Hospital Dupuytren, Limoges, France.

Xavier Dufour (X)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Poitiers, Poitiers, France.

Olivier Malard (O)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Nantes, Nantes, France.

Romina Mastronicola (R)

Surgical Oncology, Head and Neck Surgery Department, Lorraine Oncology Institute, Vandoeuvre-lès-Nancy, France.

Benjamin Vairel (B)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Hôpital Larrey, Toulouse, France.

Patrice Gallet (P)

Otolaryngology, Head and Neck Surgery Department, University Hospital of Nancy, Nancy, France.

Philippe Ceruse (P)

Otolaryngology, Head and Neck Surgery Department, University Hospital Lyon Sud, Lyon, France.

Franck Jegoux (F)

Otolaryngology, Head and Neck Surgery Department, Pontchaillou Hospital, Rennes, France.

Jean Ton Van (J)

Surgical Oncology Head and Neck Surgery Department, Oscar Lambret Centre, Lille, France.

Guillaume De Bonnecaze (G)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Hôpital Larrey, Toulouse, France.

Sébastien Vergez (S)

Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Hôpital Larrey, Toulouse, France. vergez.s@chu-toulouse.fr.
Otolaryngology, Head and Neck Surgery Department, University Hospital Larrey, 24 chemin de Pouvourville, 31059, Toulouse Cedex 9, France. vergez.s@chu-toulouse.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH